Cognitive Behavioral Therapy for Late-Life Depression (CBTlate): Results of a Multicenter, Randomized, Observer-Blinded, Controlled Trial.

Cognitive behavioral therapy Geriatric depression Late-life depression Randomized controlled trial Supportive psychotherapy

Journal

Psychotherapy and psychosomatics
ISSN: 1423-0348
Titre abrégé: Psychother Psychosom
Pays: Switzerland
ID NLM: 0024046

Informations de publication

Date de publication:
2023
Historique:
received: 31 08 2022
accepted: 23 01 2023
medline: 22 6 2023
pubmed: 3 4 2023
entrez: 2 4 2023
Statut: ppublish

Résumé

Different psychotherapeutic interventions for late-life depression (LLD) have been proposed, but their evaluation in large, multicenter trials is rare. The present study evaluated the efficacy of a specific cognitive behavioral therapy (CBT) for LLD (LLD-CBT) in comparison with a supportive unspecific intervention (SUI), both administered in a specialist psychiatric outpatient setting. In this randomized, controlled, parallel group trial, we recruited participants (≥60 years) with moderate to severe depression at 7 trial sites in Germany. Participants were randomly assigned to the LLD-CBT or SUI group. The primary outcome was depression severity at the end of treatment measured by change on the Geriatric Depression Scale (GDS). Secondary outcomes included change in observer-rated depression, anxiety, sleep ratings, and quality of life throughout the treatment phase and at 6-month follow-up. Between October 1, 2018, and November 11, 2020, we randomly assigned 251 patients to either LLD-CBT (n = 126) or SUI (n = 125), of whom 229 provided primary-outcome data. There was no significant between-group difference in the change in GDS scores at the end of treatment (estimated marginal mean difference: -1.01 [95% CI: -2.88 to 0.86]; p = 0.287). Secondary analyses showed significant improvements in several outcomes after 8 weeks and at follow-up in both treatment arms. Our data suggest that LLD-specific CBT and a supportive unspecific treatment both provide clinical benefit in patients with moderate to severe LLD without evidence for superiority of LLD-CBT.

Identifiants

pubmed: 37004508
pii: 000529445
doi: 10.1159/000529445
doi:

Types de publication

Randomized Controlled Trial Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

180-192

Informations de copyright

© 2023 The Author(s). Published by S. Karger AG, Basel.

Auteurs

Forugh S Dafsari (FS)

Department of Psychiatry and Psychotherapy, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.

Bettina Bewernick (B)

Department of Neurodegenerative Diseases and Geriatric Psychiatry, University of Bonn, Bonn, Germany.

Sabine Böhringer (S)

Department of Psychiatry and Psychotherapy, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.

Katharina Domschke (K)

Department of Psychiatry and Psychotherapy, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Moritz Elsaesser (M)

Department of Psychiatry and Psychotherapy, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Margrit Löbner (M)

Institute of Social Medicine, Occupational Health and Public Health, University of Leipzig, Leipzig, Germany.

Melanie Luppa (M)

Institute of Social Medicine, Occupational Health and Public Health, University of Leipzig, Leipzig, Germany.

Lukas Preis (L)

Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.

Julia Püsken (J)

Department of Psychiatry and Psychotherapy, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.

Sandra Schmitt (S)

Department of Geriatric Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Andreea-Johanna Szekely (AJ)

Department of Psychiatry and Psychotherapy, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.

Martin Hellmich (M)

Institute of Medical Statistics and Computational Biology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.

Wiebke Müller (W)

Institute of Medical Statistics and Computational Biology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.

Michael Wagner (M)

Department of Neurodegenerative Diseases and Geriatric Psychiatry, University of Bonn, Bonn, Germany.

Oliver Peters (O)

Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.

Lutz Frölich (L)

Department of Geriatric Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Steffi Riedel-Heller (S)

Institute of Social Medicine, Occupational Health and Public Health, University of Leipzig, Leipzig, Germany.

Elisabeth Schramm (E)

Department of Psychiatry and Psychotherapy, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Martin Hautzinger (M)

Department of Clinical Psychology and Psychotherapy, Eberhard Karls University, Tuebingen, Germany.

Frank Jessen (F)

Department of Psychiatry and Psychotherapy, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
German Center for Neurodegenerative Disease (DZNE), Bonn, Germany.
Cellular Stress Response in Aging-Associated Diseases (CECAD) Cluster of Excellence, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH